“PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events”. Canadian Cardiology Today 1, no. 1 (March 19, 2025): 20–25. Accessed March 29, 2026. https://canadiancardiologytoday.com/article/view/1-1-Abramson_et_al.